Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation
Clinical trial NCT00720629 · TERMINATED
Trial details
- NCT number
- NCT00720629
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2013-12-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.